Biomira Shares Skyrocket on Promising Data Shares of biotech company Biomira Inc. soared as it and a development partner, German drug maker Merck KGaA, reported Friday that the median survival in a study involving a lung cancer vaccine has yet to be reached after 23 months in a subset of patients.